Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis Review Article (Web of Science)

cited authors

  • Younes, Ahmed M.; Salem, Mahmoud; Maraey, Ahmed; Nomigolzar, Soroush; Sewell, Kerry; Khalil, Mahmoud; Elzanaty, Ahmed; Saeyeldin, Ayman; Dar, Moahad

publication date

  • November 1, 2022

webpage

published in

category

keywords

  • Dapagliflozin
  • Empagliflozin
  • Heart failure (HF)
  • Heart failure with preserved ejection fraction (HfpEF)
  • Heart failure with reduced ejection fraction (HfrEF)
  • Safety outcomes
  • Sodium-glucose co-transporter inhibitors (SGLT2i)
  • Sotagliflozin

start page

  • 51

end page

  • 56

volume

  • 366